Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
N
Nykode Therapeutics ASA
XMUN:5VB
Nykode Therapeutics ASA
XMUN:5VB
Price:
0.3815
EUR
-1.17%
Market Closed
Market Cap:
€756.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
N
|
Nykode Therapeutics ASA
XMUN:5VB
|
NO |
|
T
|
Texas Roadhouse Inc
SWB:ROW
|
US |
|
A
|
Allstate Corp
F:ALS
|
US |
|
A
|
AI/ML Innovations Inc
DUS:42FB
|
CA |
|
W
|
Webuild SpA
XMUN:IPJ1
|
IT |
|
H
|
HAL Trust
OTC:HALFF
|
NL |
|
P
|
Pico Far East Holdings Ltd
F:PJFB
|
HK |
|
S
|
Suedwestdeutsche Salzwerke AG
SWB:SSH
|
DE |
|
C
|
Cimpress PLC
F:3UF
|
IE |
|
NanoXplore Inc
F:N13
|
CA |
|
D
|
Denali Therapeutics Inc
F:4DN
|
US |
|
Ipsos SA
OTC:IPSOF
|
FR |
|
Orthocell Ltd
ASX:OCC
|
AU |
|
I
|
Ipsos SA
SWB:IPZ
|
FR |
Wall St Price Targets
5VB Price Forecast
Based on 4 analysts
Based on 4 analysts
+88% Upside
from
€0.3815
today
Nykode Therapeutics ASA (5VB)’s 12-month stock price forecast through October 2027 has a consensus target of €0.7153, implying 88% upside. The forecast is based on price targets from 4 Wall Street analysts.
Nykode Therapeutics ASA Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 5VB's stock price target?
Price Target
0.7153
EUR
0.7153
EUR
According to Wall Street analysts, the average 1-year price target for 5VB is 0.7153 EUR with a low forecast of 0.6233 EUR and a high forecast of 0.8247 EUR.